Australian biotech market today 03.04.09
Friday, 03 April, 2009
A very flat day’s trading on the ASX saw biotech and pharma go against the grain at the close of trade today, with a slight drop in indices as opposed to overall gains.
Starpharma (ASX:SPL) has called a trading halt until an announcement on Tuesday.
Atcor (ASX:ACG) is down 1c, which still means a 7 per cent drop in value, while Acrux (ASX:ACR) is up 3c, or 5.6 per cent.
Bionomics (ASX:BNO) is down a touch, as is Biota (ASX:BTA).
Circadian Technologies (ASX:CIR) is up 3c, as is CathRx (ASX:CXD), while Clinuvel (ASX:CUV) is up two.
With the Big Three, Cochlear (ASX:COH) has dropped below $50 while CSL (ASX:CSL) is down $1 on high volumes. ResMed (ASX:RMD) is down a touch, too.
Mesoblast (ASX:MSB) is down on a change in substantial shareholding and Pharmaxis (ASX:PXS) is still riding the wave of recent good interim data, up to $1.88.
Scientists uncover how cancer cells hide from immune system
By targeting the RNA helicase known as DDX6, scientists could enable the immune system to...
Vanillin flavouring in vapes may disrupt embryo development
Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
